Press Statement: Fluoroquinole Antibiotics, Hydrochlorthiazide Products and Valsartan Containing Products
- Version
- Download 669
- File Size 140.69 KB
- File Count 1
- Create Date February 15, 2022
- Last Updated February 15, 2022
Press Statement: Fluoroquinole Antibiotics, Hydrochlorthiazide Products and Valsartan Containing Products
These antibiotics used to treat various bacterial infections have been associated with increased risk of disabling adverse drug reactions affecting muscles, tendons and the nervous system.
Attached Files
| File | Action |
|---|---|
| Press Statement on HCTZ 14th March 2019.pdf | Download |
